1. Home
  2. SKYT vs STOK Comparison

SKYT vs STOK Comparison

Compare SKYT & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYT
  • STOK
  • Stock Information
  • Founded
  • SKYT 1991
  • STOK 2014
  • Country
  • SKYT United States
  • STOK United States
  • Employees
  • SKYT N/A
  • STOK N/A
  • Industry
  • SKYT Semiconductors
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKYT Technology
  • STOK Health Care
  • Exchange
  • SKYT Nasdaq
  • STOK Nasdaq
  • Market Cap
  • SKYT 455.4M
  • STOK 517.0M
  • IPO Year
  • SKYT 2021
  • STOK 2019
  • Fundamental
  • Price
  • SKYT $9.09
  • STOK $10.88
  • Analyst Decision
  • SKYT Strong Buy
  • STOK Strong Buy
  • Analyst Count
  • SKYT 2
  • STOK 5
  • Target Price
  • SKYT $11.50
  • STOK $24.50
  • AVG Volume (30 Days)
  • SKYT 828.3K
  • STOK 670.8K
  • Earning Date
  • SKYT 05-07-2025
  • STOK 05-13-2025
  • Dividend Yield
  • SKYT N/A
  • STOK N/A
  • EPS Growth
  • SKYT N/A
  • STOK N/A
  • EPS
  • SKYT N/A
  • STOK 0.88
  • Revenue
  • SKYT $323,929,000.00
  • STOK $190,908,000.00
  • Revenue This Year
  • SKYT N/A
  • STOK $378.84
  • Revenue Next Year
  • SKYT $22.00
  • STOK N/A
  • P/E Ratio
  • SKYT N/A
  • STOK $12.39
  • Revenue Growth
  • SKYT 7.90
  • STOK 2333.81
  • 52 Week Low
  • SKYT $5.63
  • STOK $5.35
  • 52 Week High
  • SKYT $19.00
  • STOK $17.58
  • Technical
  • Relative Strength Index (RSI)
  • SKYT 58.82
  • STOK 66.74
  • Support Level
  • SKYT $8.71
  • STOK $9.09
  • Resistance Level
  • SKYT $9.51
  • STOK $11.42
  • Average True Range (ATR)
  • SKYT 0.55
  • STOK 0.58
  • MACD
  • SKYT -0.01
  • STOK 0.11
  • Stochastic Oscillator
  • SKYT 56.25
  • STOK 76.82

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: